36.21 USD
+0.05 (+0.14%)
35.9 USD
-0.31 (-0.86%)
We assign a fundamental rating of 5 out of 10 to INDV. INDV was compared to 192 industry peers in the Pharmaceuticals industry. INDV has an excellent profitability rating, but there are some minor concerns on its financial health. INDV may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year INDV was profitable.
INDV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 8.62%, INDV belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
The Return On Invested Capital of INDV (50.62%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 12.85%.
The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
INDV has a better Profit Margin (10.34%) than 83.85% of its industry peers.
In the last couple of years the Profit Margin of INDV has declined.
INDV has a Operating Margin of 24.49%. This is amongst the best in the industry. INDV outperforms 91.67% of its industry peers.
INDV's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 85.51%, INDV belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
INDV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
INDV has a worse debt/assets ratio than last year.
2.2 Solvency
INDV has an Altman-Z score of 2.80. This is not the best score and indicates that INDV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of INDV (2.80) is better than 63.54% of its industry peers.
The Debt to FCF ratio of INDV is 2.68, which is a good value as it means it would take INDV, 2.68 years of fcf income to pay off all of its debts.
INDV has a Debt to FCF ratio of 2.68. This is amongst the best in the industry. INDV outperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.8 |
ROIC/WACC5.39
WACC9.4%
2.3 Liquidity
INDV has a Current Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.96, INDV is doing worse than 85.94% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that INDV may have some problems paying its short term obligations.
INDV's Quick ratio of 0.79 is on the low side compared to the rest of the industry. INDV is outperformed by 82.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 239.13% over the past year.
The earnings per share for INDV have been decreasing by -53.19% on average. This is quite bad
The Revenue has decreased by -0.25% in the past year.
The Revenue has been growing by 8.64% on average over the past years. This is quite good.
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
The Earnings Per Share is expected to grow by 54.72% on average over the next years. This is a very strong growth
INDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
INDV is valuated rather expensively with a Price/Earnings ratio of 18.47.
Based on the Price/Earnings ratio, INDV is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.57. INDV is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.92, which indicates a correct valuation of INDV.
83.85% of the companies in the same industry are more expensive than INDV, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, INDV is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 12.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INDV is valued cheaper than 82.81% of the companies in the same industry.
79.69% of the companies in the same industry are more expensive than INDV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.67 | ||
| EV/EBITDA | 13.94 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INDV has a very decent profitability rating, which may justify a higher PE ratio.
INDV's earnings are expected to grow with 125.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y229.55%
EPS Next 3Y125.91%
5. Dividend
5.1 Amount
INDV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
36.21
+0.05 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners93.08%
Inst Owner Change240.03%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap4.52B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84.62
Price TargetN/A
Short Float %4.77%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)159.52%
PT rev (3m)159.52%
EPS NQ rev (1m)6.31%
EPS NQ rev (3m)N/A
EPS NY rev (1m)75.01%
EPS NY rev (3m)76.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.51%
Revenue NY rev (3m)12.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 12.92 | ||
| P/S | 3.83 | ||
| P/FCF | 37.67 | ||
| P/OCF | 25.12 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.94 |
EPS(TTM)1.96
EY5.41%
EPS(NY)2.8
Fwd EY7.74%
FCF(TTM)0.96
FCFY2.65%
OCF(TTM)1.44
OCFY3.98%
SpS9.45
BVpS-1.66
TBVpS-1.67
PEG (NY)0.02
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.8 |
F-Score8
WACC9.4%
ROIC/WACC5.39
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1034.05%
EBIT Next 3Y143.47%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PLC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
Can you provide the valuation status for INDIVIOR PLC?
ChartMill assigns a valuation rating of 7 / 10 to INDIVIOR PLC (INDV). This can be considered as Undervalued.
What is the profitability of INDV stock?
INDIVIOR PLC (INDV) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for INDV stock?
The Price/Earnings (PE) ratio for INDIVIOR PLC (INDV) is 18.47 and the Price/Book (PB) ratio is -21.84.
What is the financial health of INDIVIOR PLC (INDV) stock?
The financial health rating of INDIVIOR PLC (INDV) is 4 / 10.